[Chronic myeloid leukemia--latest aspects and practical progress in recent years]

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

Blood cancer journal·2016

CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.

Cytometry. Part B, Clinical cytometry·2016

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Leukemia·2016

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

Leukemia·2016

[75-year old female with progressive idiopathic lung fibrosis].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Resistant hypertension despite nine different antihypertensive drugs?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Medizinische Klinik (Munich, Germany : 1983)·2011

Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.

Clinical transplantation·2026

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.

Immunologic research·2026

Concordance of genetic determinants of acute coronary artery disease between European and Chinese populations.

GigaScience·2026

Management of Recurrent C3 Glomerulopathy After Kidney Transplantation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Sex Based Differences in Association Between Plaque Burden and Ischemia -- a CREDENCE Trial Substudy.

European heart journal. Cardiovascular Imaging·2026

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

European heart journal·2026

Related Experiment Videos

[Chronic myeloid leukemia--latest aspects and practical progress in recent years]

Related Concept Videos

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

[75-year old female with progressive idiopathic lung fibrosis].

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

[Resistant hypertension despite nine different antihypertensive drugs?].

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.

Concordance of genetic determinants of acute coronary artery disease between European and Chinese populations.

Management of Recurrent C3 Glomerulopathy After Kidney Transplantation.

Sex Based Differences in Association Between Plaque Burden and Ischemia -- a CREDENCE Trial Substudy.

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

Related Experiment Videos

[Chronic myeloid leukemia--latest aspects and practical progress in recent years]

Related Concept Videos

Related Articles